These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27736960)

  • 21. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Efficacious Multi-Objective Fuzzy Linear Programming Approach for Optimal Power Flow Considering Distributed Generation.
    Warid W; Hizam H; Mariun N; Abdul-Wahab NI
    PLoS One; 2016; 11(3):e0149589. PubMed ID: 26954783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.
    Tristán-Noguero A; Díez H; Jou C; Pineda M; Ormazábal A; Sánchez A; Artuch R; Garcia-Cazorla À
    Metab Brain Dis; 2016 Jun; 31(3):705-9. PubMed ID: 26686676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vesicular monoamine transporter 2: role as a novel target for drug development.
    Zheng G; Dwoskin LP; Crooks PA
    AAPS J; 2006 Nov; 8(4):E682-92. PubMed ID: 17233532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic Neuronal Differentiation from the Forebrain-Derived Human Neural Stem Cells Induced in Cultures by Using a Combination of BMP-7 and Pramipexole with Growth Factors.
    Yang H; Wang J; Wang F; Liu X; Chen H; Duan W; Qu T
    Front Neural Circuits; 2016; 10():29. PubMed ID: 27147976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.
    Vergo S; Johansen JL; Leist M; Lotharius J
    Brain Res; 2007 Dec; 1185():18-32. PubMed ID: 18028884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.
    Bédard C; Wallman MJ; Pourcher E; Gould PV; Parent A; Parent M
    Parkinsonism Relat Disord; 2011 Sep; 17(8):593-8. PubMed ID: 21664855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mining metabolic networks for optimal drug targets.
    Sridhar P; Song B; Kahveci T; Ranka S
    Pac Symp Biocomput; 2008; ():291-302. PubMed ID: 18229694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for Parkinson's disease: determining the genes necessary for optimal dopamine replacement in rat models.
    Kang UJ; Lee WY; Chang JW
    Hum Cell; 2001 Mar; 14(1):39-48. PubMed ID: 11436352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.
    Miller GW; Wang YM; Gainetdinov RR; Caron MG
    Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
    Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
    Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration.
    Tong J; Wilson AA; Boileau I; Houle S; Kish SJ
    Synapse; 2008 Nov; 62(11):873-6. PubMed ID: 18720517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse ways of perturbing the human arachidonic acid metabolic network to control inflammation.
    Meng H; Liu Y; Lai L
    Acc Chem Res; 2015 Aug; 48(8):2242-50. PubMed ID: 26237215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-objective evolutionary algorithms for fuzzy classification in survival prediction.
    Jiménez F; Sánchez G; Juárez JM
    Artif Intell Med; 2014 Mar; 60(3):197-219. PubMed ID: 24525210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.